levodopa has been researched along with Albinism, Oculocutaneous in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Arveiler, B; Decoeur, F; Gazova, I; Gontier, E; Jackson, IJ; Javerzat, S; McKie, L; Mercier, E; Michaud, V; Pinson, B; Tingaud-Sequeira, A | 1 |
| Griffiths, H; Lee, H; Lotery, A; Scott, J; Self, JE | 1 |
| Anderson, JL; Brilliant, MH; Connett, JE; De Becker, I; Holleschau, AM; McKay, BS; Summers, CG | 1 |
| Cantero, M; Cediel, R; Contreras, J; Montoliu, L; Murillo-Cuesta, S; Varela-Nieto, I; Zurita, E | 1 |
| Lavado, A; Montoliu, L | 1 |
| Shimizu, H | 1 |
1 review(s) available for levodopa and Albinism, Oculocutaneous
| Article | Year |
|---|---|
New animal models to study the role of tyrosinase in normal retinal development.
Topics: Albinism; Albinism, Oculocutaneous; Animals; Chromosomes, Artificial, Bacterial; Chromosomes, Artificial, Yeast; Crosses, Genetic; Disease Models, Animal; Exons; Gene Expression Regulation; Levodopa; Melanins; Mice; Mice, Transgenic; Models, Genetic; Monophenol Monooxygenase; Mutation; Phenotype; Retina; Transcriptional Activation; Transgenes | 2006 |
1 trial(s) available for levodopa and Albinism, Oculocutaneous
| Article | Year |
|---|---|
Does levodopa improve vision in albinism? Results of a randomized, controlled clinical trial.
Topics: Administration, Oral; Adolescent; Adult; Albinism, Oculocutaneous; Child; Child, Preschool; Dopamine Agents; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Prospective Studies; Visual Acuity | 2014 |
4 other study(ies) available for levodopa and Albinism, Oculocutaneous
| Article | Year |
|---|---|
The
Topics: Albinism; Albinism, Oculocutaneous; Animals; Disease Models, Animal; Humans; Intramolecular Oxidoreductases; Levodopa; Melanosomes; Mice; Monophenol Monooxygenase | 2022 |
Oral levodopa rescues retinal morphology and visual function in a murine model of human albinism.
Topics: Administration, Oral; Albinism, Oculocutaneous; Animals; Antiparkinson Agents; Disease Models, Animal; Humans; Levodopa; Mice; Mice, Inbred C57BL; Retina; Vision, Ocular | 2019 |
Melanin precursors prevent premature age-related and noise-induced hearing loss in albino mice.
Topics: Aging; Aging, Premature; Albinism; Albinism, Oculocutaneous; Animals; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Gene Expression Regulation, Enzymologic; Genetic Predisposition to Disease; Hearing Loss, Noise-Induced; Hearing Loss, Sensorineural; Levodopa; Melanins; Mice; Mice, Transgenic; Monophenol Monooxygenase; Tyrosine 3-Monooxygenase | 2010 |
Technical advances in prenatal diagnosis of tyrosinase-negative oculocutaneous albinism.
Topics: Albinism, Oculocutaneous; Female; Histocytochemistry; Humans; Levodopa; Male; Melanocytes; Monophenol Monooxygenase; Mutation; Pregnancy; Prenatal Diagnosis; Skin | 1997 |